Showing results (21-30 of 76) with videos related to
Sort By:
Pageof 8
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|December 1, 2010
[Clinical and prognostic significance of serum MMP-9, endostatin and VEGF in patients with advanced non-small cell lung cancer]Xuebing Li, Baolan Li, Baitang Lai, et al.Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|February 22, 2013
[Combining bevacizumab with endostatin gets better antitumor efficacy in vivo in lung cancer animal model]Niu Niu, Baolan Li, Chaoyang Liu, et al.Oncology Letters|May 1, 2023
Beneficial effects of postoperative radiotherapy for IIIA‑N2 non‑small cell lung cancer after radical resection analysed using the propensity score‑matching methodCuimeng Tian, Guimei Liu, Yongxiang Xu, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 28, 2020
Development of an LC-MS/MS method for quantifying ASK120067, a novel mutant-selective inhibitor of the epidermal growth factor receptor (EGFR) as well as its main metabolite in human plasma and its application in a pharmacokinetic studyXinge Cui, Shaoyuan Wang, Huitao Gao, et al.Biochemical and Biophysical Research Communications|March 26, 2019
The m6A demethylase FTO promotes the growth of lung cancer cells by regulating the m6A level of USP7 mRNAJie Li, Yi Han, Hongmei Zhang, et al.BMC Cancer|October 4, 2012
Downregulation of cyclophilin A by siRNA diminishes non-small cell lung cancer cell growth and metastasis via the regulation of matrix metallopeptidase 9Zhe Qian, Xiaoting Zhao, Mei Jiang, et al.Experimental and Therapeutic Medicine|January 10, 2015
Association between VEGFR-3 expression and lymph node metastasis in non-small-cell lung cancerJie Li, Han Yi, Zhidong Liu, et al.Immunotherapy|May 16, 2022
Combined application of bevacizumab and PD-1 blockade displays durable treatment effects by increasing the infiltration and cytotoxic function of CD8+ T cells in lung cancerYanxia Liu, Tongmei Zhang, Lina Zhang, et al.Therapeutic Advances in Medical Oncology|December 23, 2024
Immuno-combined treatment versus radio-combined treatment in limited-stage small-cell lung cancerLi Tong, Xiaomi Li, Mingming Hu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2014
Plasma levels of heat shock protein 90 alpha associated with lung cancer development and treatment responsesYuankai Shi, Xiaoqing Liu, Jiatao Lou, et al.Pageof 8